Literature DB >> 8757849

Immune response in mice following immunization with DNA encoding fragment C of tetanus toxin.

R Anderson1, X M Gao, A Papakonstantinopoulou, M Roberts, G Dougan.   

Abstract

Tetanus toxin is a potent neurotoxin synthesized by Clostridium tetani. Immunization with fragment C protein, the nontoxic C-terminal domain of tetanus toxin, will protect mice against lethal challenge with tetanus toxin. A synthetic gene encoding fragment C (tetC) had previously been shown to express high levels of fragment C in Saccharomyces cerevisiae. A plasmid, pcDNA3/tetC, which encodes the synthetic tetC gene expressed under the control of the human cytomegalovirus major intermediate-early promoter/enhancer region, was constructed. Expression of fragment C was observed in eukaryotic cells growing in vitro following transfection with pcDNA3/tetC. The immune response induced by intramuscular immunization with pure pcDNA3/tetC DNA was evaluated in a murine model. Anti-fragment C serum immunoglobulin and proliferative responses in splenocytes were observed in BALB/c mice following two immunizations with pcDNA3/tetC. The major immunoglobulin G subclass that recognized fragment C was immunoglobulin G2a, and the stimulated splenocytes secreted high levels of gamma interferon. Immunity to tetanus is dependent on the presence of neutralizing serum antibodies against tetanus toxin. Sufficient anti-fragment C serum immunoglobulins were induced by DNA-mediated immunization to protect mice against lethal challenge with tetanus toxin.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8757849      PMCID: PMC174203          DOI: 10.1128/iai.64.8.3168-3173.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  47 in total

1.  High-level expression of tetanus toxin fragment C in Pichia pastoris strains containing multiple tandem integrations of the gene.

Authors:  J J Clare; F B Rayment; S P Ballantine; K Sreekrishna; M A Romanos
Journal:  Biotechnology (N Y)       Date:  1991-05

2.  Synthesis of tetanus toxin fragment C in insect cells by use of a baculovirus expression system.

Authors:  I G Charles; B C Rodgers; A J Makoff; S N Chatfield; D E Slater; N F Fairweather
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

3.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

4.  Structure of tetanus toxin. I. Breakdown of the toxin molecule and discrimination between polypeptide fragments.

Authors:  T B Helting; O Zwisler
Journal:  J Biol Chem       Date:  1977-01-10       Impact factor: 5.157

5.  Interaction of fragments B and C of tetanus toxin with neural and thyroid membranes and with gangliosides.

Authors:  N P Morris; E Consiglio; L D Kohn; W H Habig; M C Hardegree; T B Helting
Journal:  J Biol Chem       Date:  1980-07-10       Impact factor: 5.157

6.  Immunization of mice against tetanus with fragments of tetanus toxin synthesized in Escherichia coli.

Authors:  N F Fairweather; V A Lyness; D J Maskell
Journal:  Infect Immun       Date:  1987-11       Impact factor: 3.441

7.  Anti-viral immunity induced by recombinant nucleoprotein of influenza A virus. III. Delivery of recombinant nucleoprotein to the immune system using attenuated Salmonella typhimurium as a live carrier.

Authors:  J P Tite; X M Gao; C M Hughes-Jenkins; M Lipscombe; D O'Callaghan; G Dougan; F Y Liew
Journal:  Immunology       Date:  1990-08       Impact factor: 7.397

8.  Expression of tetanus toxin fragment C in yeast: gene synthesis is required to eliminate fortuitous polyadenylation sites in AT-rich DNA.

Authors:  M A Romanos; A J Makoff; N F Fairweather; K M Beesley; D E Slater; F B Rayment; M M Payne; J J Clare
Journal:  Nucleic Acids Res       Date:  1991-04-11       Impact factor: 16.971

9.  Oxygen dependence of omeprazole clearance and sulfone and sulfide metabolite formation in the isolated perfused rat liver.

Authors:  P W Angus; G W Mihaly; D J Morgan; R A Smallwood
Journal:  J Pharmacol Exp Ther       Date:  1989-09       Impact factor: 4.030

10.  Immune response to a carcinoembryonic antigen polynucleotide vaccine.

Authors:  R M Conry; A F LoBuglio; J Kantor; J Schlom; F Loechel; S E Moore; L A Sumerel; D L Barlow; S Abrams; D T Curiel
Journal:  Cancer Res       Date:  1994-03-01       Impact factor: 12.701

View more
  12 in total

1.  Expression of tetanus toxin Fragment C in tobacco chloroplasts.

Authors:  John S Tregoning; Peter Nixon; Hiroshi Kuroda; Zora Svab; Simon Clare; Frances Bowe; Neil Fairweather; Jimmy Ytterberg; Klaas J van Wijk; Gordon Dougan; Pal Maliga
Journal:  Nucleic Acids Res       Date:  2003-02-15       Impact factor: 16.971

2.  Acute and chronic phases of Toxoplasma gondii infection in mice modulate the host immune responses.

Authors:  T D Nguyen; G Bigaignon; J Van Broeck; M Vercammen; T N Nguyen; M Delmee; M Turneer; S F Wolf; J P Coutelier
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

3.  DNA immunization circumvents deficient induction of T helper type 1 and cytotoxic T lymphocyte responses in neonates and during early life.

Authors:  X Martinez; C Brandt; F Saddallah; C Tougne; C Barrios; F Wild; G Dougan; P H Lambert; C A Siegrist
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-05       Impact factor: 11.205

4.  Targeting improves the efficacy of a DNA vaccine against Corynebacterium pseudotuberculosis in sheep.

Authors:  P J Chaplin; R De Rose; J S Boyle; P McWaters; J Kelly; J M Tennent; A M Lew; J P Scheerlinck
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

5.  Candidate live, attenuated Salmonella enterica serotype Typhimurium vaccines with reduced fecal shedding are immunogenic and effective oral vaccines.

Authors:  Moataz Abd El Ghany; Angela Jansen; Simon Clare; Lindsay Hall; Derek Pickard; Robert A Kingsley; Gordon Dougan
Journal:  Infect Immun       Date:  2007-02-12       Impact factor: 3.441

6.  Reduction of the ganglioside binding activity of the tetanus toxin HC fragment destroys immunogenicity: implications for development of novel tetanus vaccines.

Authors:  Omar Qazi; Dorothea Sesardic; Robert Tierney; Zahra Söderbäck; Dennis Crane; Barbara Bolgiano; Neil Fairweather
Journal:  Infect Immun       Date:  2006-08       Impact factor: 3.441

Review 7.  Immunization with DNA vaccines in early life: advantages and limitations as compared to conventional vaccines.

Authors:  C A Siegrist; P H Lambert
Journal:  Springer Semin Immunopathol       Date:  1997

8.  Multimeric bivalent immunogens from recombinant tetanus toxin HC fragment, synthetic hexasaccharides, and a glycopeptide adjuvant.

Authors:  Aileen F G Bongat; Rina Saksena; Roberto Adamo; Yukari Fujimoto; Zenyu Shiokawa; Dwight C Peterson; Koichi Fukase; Willie F Vann; Pavol Kovác
Journal:  Glycoconj J       Date:  2009-09-16       Impact factor: 2.916

9.  Chemoenzymatic synthesis of immunogenic meningococcal group C polysialic acid-tetanus Hc fragment glycoconjugates.

Authors:  Pumtiwitt C McCarthy; Rina Saksena; Dwight C Peterson; Che-Hung Lee; Yanming An; John F Cipollo; Willie F Vann
Journal:  Glycoconj J       Date:  2013-08-16       Impact factor: 2.916

Review 10.  Tetanus toxin C-fragment: the courier and the cure?

Authors:  Janne M Toivonen; Sara Oliván; Rosario Osta
Journal:  Toxins (Basel)       Date:  2010-10-29       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.